Business

Myomo to Report Fourth Quarter 2025 Financial Results on March 9

BURLINGTON, Mass., March 02, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business updat

articleMyomo Inc.March 2, 20262/company/myomo-inc/news/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9
Myomo to Report Fourth Quarter 2025 Financial Results on March 9

About this update from Myomo Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":898,"height":230,"url":"https://media.zenfs.com/en/business-wire.com/361379ab7474371dc135f959699572c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.4RJLhsq4J4Bc0r0b448Yg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/361379ab7474371dc135f959699572c0","width":898,"height":230},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/A3hLNnIJvvAncwuwODqF4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE3OTY7aD00NjA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/361379ab7474371dc135f959699572c0","width":898,"height":230}},"lazy":false},{"type":"text","content":"BURLINGTON, Mass., March 02, 2026--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.","length":560,"tagName":"p"},{"type":"text","content":"Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those unable to pre-register can participate by dialing 844-707-6932 (U.S.) or 412-317-9250 (International). A webcast of the call can be accessed at https://ir.myomo.com/.","length":411,"tagName":"p"},{"type":"text","content":"A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at https://ir.myomo.com/. A dial-in replay of the call will be available until March 23, 2026 at 855-669-9658 (U.S. and Canada toll free), or 412-317-0088 (International toll), using access code 8067458.","length":327,"tagName":"p"},{"type":"text","content":"About Myomo, Inc.","length":17,"tagName":"p"},{"type":"text","content":"Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand funct...

More updates from Myomo Inc.

Myomo, Inc.neurological disordersmedical roboticsBUSINESS WIRE